New combo therapy aims to control early-spread prostate cancer
NCT ID NCT04619069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a precise type of radiation (SBRT) to intermittent hormone therapy can better control prostate cancer that has spread to a few places in the body. The trial involves 60 men whose cancer was detected by a special PET scan but not by standard scans. The main goal is to see how many patients are willing to join the study, and researchers will also track side effects and how well the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stereotactic body radiotherapy (SBRT) and intermittent hormone therapy
- What this could lead to
- If successful, this could show that adding targeted radiation to hormone therapy helps control prostate cancer that has spread to a few spots, potentially delaying disease progression.
- What could go wrong
- This is an early feasibility study with only 60 participants, so results may not be conclusive. The added radiation could cause side effects, and the benefit over hormone therapy alone is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONE SENSITIVE OLIGOMETASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Odette Cancer Centre
Toronto, Ontario, M4N3M5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?